This finding closely parallels luteolin’s ability to suppress NLRP3-driven pyroptosis, reinforcing the therapeutic potential of modulating the NLRP3 pathway in ALI/ARDS. This evidence concerns the gene NLRP3 and acute respiratory distress syndrome.